Erratum

Online summary

Corrections to: Donatucci CF, Wong DG, Giuliano F, et al. Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Curr Med Res Opin 2008;24:3383-92; doi: 10.1185/03007990802498440.

View correction statement:

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option

This article refers to:

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option

Corrections to: Donatucci CF, Wong DG, Giuliano F, et al. Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Curr Med Res Opin 2008;24:3383-92; doi: 10.1185/03007990802498440.

The authors report that, due to an oversight, a typographical error occurred in Table 7: in the “Placebo” column, the N should be reported as “N = 148”.

In addition, in Table 2, the “ED severity (IIEF EF score range)”, “Mild” row, should be reported as (“17--30”). The percentage of men reported in the “Tadalafil as needed” column should be 40%. The following is a corrected Table 2.

Table 2.  Demographics and baseline characteristics for men with ED in the general population who participated in tadalafil once daily trials or in the tadalafil as needed trials.

	Tadafil once daily		Tadafil as needed
	Porst et al. 2006^11 (N = 268)	Rajfer et al. 2007^12 (N = 287)	Carson et al. 2004^9 (N = 2102)
Mean age (range), years	56 (21--78)	60 (26--82)	56 (22--88)
>65 years	22%	34%	23%
ED duration ≥1 yr	93%	96%	88%
ED cause
Organic	43%	68%	58%
Psychogenic	24%	4%	12%
Mixed	34%	28%	31%
IIEF EF mean baseline score	13.4	13.4	14.5
ED severity (IIEF EF score range)
Mild (17--30)	33%	35%	40%
Moderate (11--16)	27%	26%	27%
Severe (1--10)	40%	39%	33%
Common co-morbid conditions
Coronary artery disease	5%	10%	5%
Depression	3%	8%	4%
Diabetes mellitus	15%	14%	20%
Hyperlipidemia	10%	22%	16%
Hypertension	29%	43%	29%

ED – erectile dysfunction; IIEF EF – International Index of Erectile Function, Erectile Function domain.